In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma.

J Exp Clin Cancer Res · 2024 · PMC11401350 · PMID 39272178

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The CD8-LV coding for anti-CD4CAR resulted in a highly significant increased survival (80%) of the CAR group compared to the control group injected with CD8-LV coding for GFP (Fig. 5 B).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.